Premier Polyfilm Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 10:59 pm

Competitors of Premier Polyfilm Ltd

All Competitor Stocks of Premier Polyfilm Ltd

Quarterly Result

Last Updated: August 1, 2025, 2:25 pm

Below is a detailed analysis of the quarterly data for Premier Polyfilm Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 65.09 Cr.. The value appears to be declining and may need further review. It has decreased from 72.13 Cr. (Mar 2025) to 65.09 Cr., marking a decrease of 7.04 Cr..
• For Expenses, as of Jun 2025, the value is 55.44 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 63.17 Cr. (Mar 2025) to 55.44 Cr., marking a decrease of 7.73 Cr..
• For Operating Profit, as of Jun 2025, the value is 9.65 Cr.. The value appears strong and on an upward trend. It has increased from 8.96 Cr. (Mar 2025) to 9.65 Cr., marking an increase of 0.69 Cr..
• For OPM %, as of Jun 2025, the value is 14.83%. The value appears strong and on an upward trend. It has increased from 12.42% (Mar 2025) to 14.83%, marking an increase of 2.41%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Interest, as of Jun 2025, the value is 0.24 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.28 Cr. (Mar 2025) to 0.24 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 1.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.29 Cr. (Mar 2025) to 1.17 Cr., marking a decrease of 0.12 Cr..
• For Profit before tax, as of Jun 2025, the value is 8.24 Cr.. The value appears strong and on an upward trend. It has increased from 7.39 Cr. (Mar 2025) to 8.24 Cr., marking an increase of 0.85 Cr..
• For Tax %, as of Jun 2025, the value is 27.18%. The value appears to be increasing, which may not be favorable. It has increased from 24.36% (Mar 2025) to 27.18%, marking an increase of 2.82%.
• For Net Profit, as of Jun 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.59 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 0.41 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.57. The value appears strong and on an upward trend. It has increased from 0.53 (Mar 2025) to 0.57, marking an increase of 0.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:15 pm

Growth

Last Updated: September 5, 2025, 12:40 pm

Balance Sheet

Last Updated: September 10, 2025, 2:19 pm

Below is a detailed analysis of the balance sheet data for Premier Polyfilm Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 107.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Mar 2024) to 107.00 Cr., marking an increase of 23.00 Cr..
• For Borrowings, as of Mar 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 9.00 Cr. (Mar 2024) to 18.00 Cr., marking an increase of 9.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 27.00 Cr.. The value appears to be improving (decreasing). It has decreased from 29.00 Cr. (Mar 2024) to 27.00 Cr., marking a decrease of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 163.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 132.00 Cr. (Mar 2024) to 163.00 Cr., marking an increase of 31.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2024) to 56.00 Cr., marking an increase of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 4.00 Cr..
• For Other Assets, as of Mar 2025, the value is 94.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2024) to 94.00 Cr., marking an increase of 23.00 Cr..
• For Total Assets, as of Mar 2025, the value is 163.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Mar 2024) to 163.00 Cr., marking an increase of 31.00 Cr..

Notably, the Reserves (107.00 Cr.) exceed the Borrowings (18.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Premier Polyfilm Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 5.00 (Mar 24) to 1.00, marking a decrease of 4.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 5. It has decreased from 9.83 (Mar 24) to 2.48, marking a decrease of 7.35.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 5. It has decreased from 9.83 (Mar 24) to 2.48, marking a decrease of 7.35.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 3. It has decreased from 12.16 (Mar 24) to 2.93, marking a decrease of 9.23.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 11.13. It has decreased from 44.58 (Mar 24) to 11.13, marking a decrease of 33.45.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 11.13. It has decreased from 44.58 (Mar 24) to 11.13, marking a decrease of 33.45.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.75 (Mar 24) to 0.15, marking a decrease of 0.60.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 28.46. It has decreased from 122.80 (Mar 24) to 28.46, marking a decrease of 94.34.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 3.86. This value is within the healthy range. It has decreased from 16.27 (Mar 24) to 3.86, marking a decrease of 12.41.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.38. This value is within the healthy range. It has decreased from 13.84 (Mar 24) to 3.38, marking a decrease of 10.46.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.27. This value is within the healthy range. It has decreased from 12.88 (Mar 24) to 3.27, marking a decrease of 9.61.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.45. This value is within the healthy range. It has decreased from 9.73 (Mar 24) to 2.45, marking a decrease of 7.28.
• For PBDIT Margin (%), as of Mar 25, the value is 13.55. This value is within the healthy range. It has increased from 13.25 (Mar 24) to 13.55, marking an increase of 0.30.
• For PBIT Margin (%), as of Mar 25, the value is 11.87. This value is within the healthy range. It has increased from 11.26 (Mar 24) to 11.87, marking an increase of 0.61.
• For PBT Margin (%), as of Mar 25, the value is 11.49. This value is within the healthy range. It has increased from 10.48 (Mar 24) to 11.49, marking an increase of 1.01.
• For Net Profit Margin (%), as of Mar 25, the value is 8.62. This value is within the healthy range. It has increased from 7.92 (Mar 24) to 8.62, marking an increase of 0.70.
• For Return on Networth / Equity (%), as of Mar 25, the value is 22.04. This value is within the healthy range. It has increased from 21.81 (Mar 24) to 22.04, marking an increase of 0.23.
• For Return on Capital Employeed (%), as of Mar 25, the value is 28.32. This value is within the healthy range. It has increased from 27.78 (Mar 24) to 28.32, marking an increase of 0.54.
• For Return On Assets (%), as of Mar 25, the value is 15.80. This value is within the healthy range. It has increased from 15.47 (Mar 24) to 15.80, marking an increase of 0.33.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.03. It has increased from 1.92 (Mar 24) to 2.03, marking an increase of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 2.49. This value is within the healthy range. It has increased from 2.48 (Mar 24) to 2.49, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.65, marking a decrease of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.13. This value is within the healthy range. It has decreased from 6.25 (Mar 24) to 6.13, marking a decrease of 0.12.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.04 (Mar 24) to 0.00, marking a decrease of 5.04.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.03 (Mar 24) to 0.00, marking a decrease of 4.03.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.96 (Mar 24) to 0.00, marking a decrease of 94.96.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.97 (Mar 24) to 0.00, marking a decrease of 95.97.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 35.22. This value is within the healthy range. It has increased from 16.90 (Mar 24) to 35.22, marking an increase of 18.32.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.41. This value is within the healthy range. It has increased from 11.10 (Mar 24) to 23.41, marking an increase of 12.31.
• For Enterprise Value (Cr.), as of Mar 25, the value is 633.42. It has increased from 407.90 (Mar 24) to 633.42, marking an increase of 225.52.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.57 (Mar 24) to 2.13, marking an increase of 0.56.
• For EV / EBITDA (X), as of Mar 25, the value is 15.68. This value exceeds the healthy maximum of 15. It has increased from 11.83 (Mar 24) to 15.68, marking an increase of 3.85.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.16. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 2.16, marking an increase of 0.57.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 94.95 (Mar 24) to 0.00, marking a decrease of 94.95.
• For Price / BV (X), as of Mar 25, the value is 5.53. This value exceeds the healthy maximum of 3. It has increased from 4.37 (Mar 24) to 5.53, marking an increase of 1.16.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.16. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 2.16, marking an increase of 0.57.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness